Management of progressive type 2 diabetes: Role of insulin therapy

Osteopathic Medicine and Primary Care

Volumn 3, Issue , 2009, Pages

  Chemitiganti, Ramachandra Rahul V ^a   Spellman, Craig W ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68349115915     PISSN: None     EISSN: 17504732     Source Type: Journal    
DOI: 10.1186/1750-4732-3-5     Document Type: Review

References (58)

1. Centers for Disease Control and Prevention National diabetes fact sheet: General information and national estimates on diabetes in the United States 2007 http://www.diabeteseducator.org/export/sites/aade/_resources/ pdf/National_Diabetes_Fact_Sheet_2008FINAL.pdf
2. National Institutes of Health National Diabetes Statistics 2007 2007 http://diabetes.niddk.nih.gov/DM/PUBS/statistics/#allages
3. International Diabetes Federation Diabetes Atlas International Diabetes Federation 3 2007
4. Saydah SH Fradkin J Cowie CC Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes JAMA 2004, 291:335-342 10.1001/jama.291.3.335 14734596
5. Hoerger TJ Segel JE Gregg EW Saaddine JB Is glycemic control improving in U.S. adults? Diabetes Care 2008, 31:81-86 10.2337/dc07-1572 17934153
6. American Diabetes Association Standards of medical care in diabetes - 2008 Diabetes Care 2008, 31(Suppl 1):S12-S54 10.2337/dc08-S012 18165335
7. Jellinger PS Davidson JA Blonde L Einhorn D Grunberger G Handelsman Y Hellman R Lebovitz H Levy P Roberts VL Road maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task Force Endocr Pract 2007, 13:260-268 17599857
8. Nathan DM Buse JB Davidson MB Ferrannini E Holman RR Sherwin R Zinman B Medical management of hyperglycemia in type 2 diabetes: A consenus algorithm for the initiation and adjustment of therapy Diabetes Care 2009, 32:193-203 10.2337/dc08-9025 18945920
9. Texas Diabetes Council Glycemic control algorithm for type 2 diabetes mellitus in children and adults 2008 http://www.dshs.state.tx.us/ diabetes/PDF/algorithms/Type 2 Glycemic Control.pdf
10. Pierce M Keen H Bradley C Risk of diabetes in offspring of parents with non-insulin dependent diabetes Diabet Med 1995, 12:6-13 7712706
11. van Haeften TW Dubbeldam S Zonderland ML Erkelens DW Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests Diabetes Care 1998, 21:278-282 10.2337/diacare.21.2.278 9539996
12. Warram JH Martin BC Krolewski AS Soeldner JS Kahn CR Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents Ann Intern Med 1990, 113:909-915 2240915
13. Groop L Genetics of the metabolic syndrome Br J Nutr 2000, 83(Suppl 1):S39-S48 10889791
14. Norris SL Zhang X Avenell A Gregg E Bowman B Schmid CH Lau J Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review Am J Prev Med 2005, 28:126-139 10.1016/j.amepre.2004.08.006 15626569
15. Klein S Sheard NF Pi-Sunyer X daly A Wylie-Rosett J Kulkarni K Clark NG Weight management through lifestyle modification for the prevention and management of type 2Adiabetes: Rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition Diabetes Care 2004, 27:2067-2073 10.2337/diacare.27.8.2067 15277443
16. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 2002, 346:393-403 1370926 11832527 10.1056/NEJMoa012512
17. Tuomilehto J Lindstrom J Eriksson JG Valle TT Hamalainen H Ilanne-Parikka P Keinanen-Kiukaanniemi S Laakso M Louheranta A Rastas M Salminen V Aunola S Cepaitis Z Moltchanov V Hakumaki M Mannelin M Martikkala V Sundvall J Uusitupa M Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance N Engl J Med 2001, 344:1343-1350 10.1056/NEJM200105033441801 11333990
18. Pan X-R Li G-W Hu Y-H Wang JX Yang WY An ZX Hu ZX Lin J Xiao JZ Cao HB Liu PA Jiang XG Jiang YY Wang JP Zheng H Zheng H Bennett PH Howard BV Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study Diabetes Care 1997, 20:537-544 10.2337/diacare.20.4.537 9096977
19. Harris R Donahue K Rathore SS Frame P Woolf SH Lohr KN Screening adults for type 2 diabetes: A review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 2003, 138:215-229 12558362
20. Texas Diabetes Council Medical nutrition algorithm IFG/type 2 diabetes prevention and therapy 2006 http://www.dshs.state.tx.us/diabetes/PDF/ algorithms/NUTRITIO.PDF
21. The Look AHEAD Research Group Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: One-year results of the look AHEAD trial Diabetes Care 2007, 30:1374-1383 2665929 17363746 10.2337/dc07-0048
22. O'Sullivan JB Diabetes mellitus after GDM Diabetes 1991, 40(Suppl 2):131-135 1748242
23. Buchanan TA Xiang AH Gestational diabetes mellitus J Clin Invest 2005, 115:485-491 1052018 15765129
24. Schaefer-Graf UM Buchanan TA Xiang AH Peters RK Kjos SL Clinical predictors for a high risk for the development of diabetes mellitus in the early puerperium in women with recent gestational diabetes mellitus Am J Obstet Gynecol 2002, 186:751-756 10.1067/mob.2002.121895 11967502
25. Xiang AH Peters RK Kjos SL Marroquin A Goico J Ochoa C Kawakubo M Buchanan TA Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes Diabetes 2006, 55:517-522 1389697 16443789 10.2337/diabetes.55.02.06.db05-1066
26. Landin-Olsson M Latent autoimmune diabetes in adults Ann N Y Acad Sci 2002, 958:112-116 12021090
27. Silverstein J Klingensmith G Copeland K Plotnick L Kaufman F Laffel L Deeb L Grey M Anderson B Holzmeister LA Clark N Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association Diabetes Care 2005, 28:186-212 10.2337/diacare.28.1.186 15616254
28. Nissen SE Nicholls SJ Wolski K Nesto R Kupfer S Perez A Jure H De Larochellière R Staniloae CS Mavromatis K Saw J Hu B Lincoff AM Tuzcu EM Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: The PERISCOPE randomized controlled trial JAMA 2008, 299:1561-1573 10.1001/ jama.299.13.1561 18378631
29. Takeda Pharmaceuticals America I. Actos® (pioglitazone hydrochloride) Tablets [Prescribing Information] 2007
30. Starner CI Schafer JA Heaton AH Gleason PP Rosiglitazone and pioglitazone utilization from January 2007 through May 2008 associated with five risk-warning events J Manag Care Pharm. 2008, 14(6):523-531 18693776
31. Faich GA Moseley RH Troglitazone (Rezulin) and hepatic injury Pharmacoepidemiol Drug Saf 2001, 10:537-547 10.1002/pds.652 11828837
32. Shorr RI Ray WA Daugherty JR Griffin MR Individual sulfonylureas and serious hypoglycemia in older people J Am Geriatr Soc 1996, 44:751-755 8675920
33. Stahl M Berger W Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long-acting versus short-acting sulphonylureas Diabet Med 1999, 16:586-590 10.1046/ j.1464-5491.1999.00110.x 10445835
34. van Staa T Abenhaim L Monette J Rates of hypoglycemia in users of sulfonylureas J Clin Epidemiol 1997, 50:735-741 10.1016/ S0895-4356(97)00024-3 9250272
35. Draeger KE Wernicke-Panten K Lomp HJ Schuler E Rosskamp R Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): A double-blind comparison with glibenclamide Horm Metab Res 1996, 28:419-425 10.1055/s-2007-979830 8911976
36. Riddle MC Glycemic management of type 2 diabetes: An emerging strategy with oral agents, insulins, and combinations Endocrinol Metab Clin North Am 2005, 34:77-98 10.1016/j.ecl.2004.12.002 15752923
37. Buse JB Henry RR Han J Kim DD Fineman MS Baron AD Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes Diabetes Care 2004, 27:2628-2635 10.2337/ diacare.27.11.2628 15504997
38. Gerstein HC Mann JFE Yi Q Zinman B Dinneen SF Hoogwerf B Hallé JP Young J Rashkow A Joyce C Nawaz S Yusuf S Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 2001, 286:421-426 10.1001/jama.286.4.421 11466120
39. Ruggenenti P Fassi A Ilieva PA Bruno S Iliev IP Brusegan V Rubis N Gherardi G Arnoldi F Ganeva M Ene-Iordache B Gaspari F Perna A Bossi A Trevisan R Dodesini AR Remuzzi G Preventing microalbuminuria in type 2 diabetes N Engl J Med 2004, 351:1941-1951 10.1056/NEJMoa042167 15516697
40. Coonrod BA Insulin syringes and pens: Finding the best match for your patients' needs Clin Diabetes 1997, 15:114-120
41. Boland EA Grey M Oesterle A Fredrickson L Tamborlane WV Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes Diabetes Care 1999, 22:1779-1784 10.2337/diacare.22.11.1779 10546007
42. Guerci B Sauvanet JP Subcutaneous insulin: Pharmacokinetic variability and glycemic variability Diabetes Metabolism 2005, 31:4S7-4S24 10.1016/ S1262-3636(05)88263-1 16389894
43. Heinemann L Variability of insulin absorption and insulin action Diabetes Technol Ther 2002, 4:673-682 10.1089/152091502320798312 12450450
44. Gin H Hanaire-Broutin H Reproducibility and variability in the action of injected insulin Diabetes Metabolism 2005, 31:7-13 10.1016/ S1262-3636(07)70160-X 15803107
45. Gerich JE Novel insulins: Expanding options in diabetes management Am J Med 2002, 113:308-316 10.1016/S0002-9343(02)01176-2 12361817
46. Yki-Jarvinen H Dressler A Ziemen M Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes Diabetes Care 2000, 23:1130-1136 10.2337/ diacare.23.8.1130 10937510
47. Philis-Tsimikas A Charpentier G Clauson P Martinez Ravn G Roberts VL Thorsteinsson B Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes Clin Ther 2006, 28:1569-1581 10.1016/ j.clinthera.2006.10.020 17157113
48. Davies M Storms F Shutler S Bianchi-Biscay M Gomis R Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine Diabetes Care 2005, 28:1282-1288 10.2337/diacare.28.6.1282 15920040
49. Garber AJ Wahlen J Wahl T Bressler P Braceras R Allen E Jain R Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (the 1-2-3 study) Diabetes Obes Metab 2006, 8:58-66 10.1111/j.1463-1326.2005.00563.x 16367883
50. Raskin P Allen E Hollander P Lewin A Gabbay RA Hu P Bode B Garber A Initiating insulin therapy in type 2 diabetes: A comparison of biphasic and basal insulin analogs Diabetes Care 2005, 28:260-265 10.2337/ diacare.28.2.260 15677776
51. Meneghini L Koenen C Weng W Selam JL The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes - results of the randomized, controlled PREDICTIVE™ 303 study Diabetes Obes Metab 2007, 9:902-913 10.1111/ j.1463-1326.2007.00804.x 17924873
52. Luzio S Dunseath G Peter R Pauvaday V Owens DR Comparison of the pharmacokinetics and pharmacodynamics of biphasic insulin aspart and insulin glargine in people with type 2 diabetes Diabetologia. 2006, 49(6):1163-1168 10.1007/s00125-006-0243-2 16596358
53. Texas Diabetes Council Insulin algorithm for type 1 diabetes mellitus in children and adults 2006 http://www.dshs.state.tx.us/diabetes/PDF/ algorithms/INST1.pdf
54. Bergenstal RM Johnson M Powers MA Wynne A Vlajnic A Hollander P Rendell M Adjust to target in type 2 diabetes: Comparison of a simple algorithm to carbohydrate counting for adjustment of mealtime insulin glulisine Diabetes Care 2008, 31:1305-1310 2453649 18364392 10.2337/dc07-2137
55. The Action to Control Cardiovascular Risk in Diabetes Study Group Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 2008, 358:2545-2559 10.1056/NEJMoa0802743 18539917
56. United Kingdom Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 1998, 352:837-853 10.1016/ S0140-6736(98)07019-6 9742976
57. Haffner SM Lehto S Rönnemaa T Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction N Engl J Med 1998, 339:229-243 10.1056/NEJM199807233390404 9673301
58. The ADVANCE Collaborative Group Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 2008, 358:2560-2572 10.1056/NEJMoa0802987 18539916